Five things for pharma marketers to know The Food and Drug Administration approved Novartis’ treatment for adults with a rare, serious blood disorder known as paroxysmal nocturnal hemoglobinuria (PNH). Pfizer decided to...

Japan’s Shionogi & Co Ltd and Swiss drugmaker Roche won U.S. Food and Drug Administration (FDA) approval for their flu treatment, the first new flu drug approved by the agency in nearly 20 years.

Astellas Pharma Inc. announced that the European Commission (EC) has approved the oral once─daily therapy Xospata (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory

Roche’s Columvi receives US FDA approval to treat people with relapsed or refractory diffuse large B─cell lymphoma Roche announced that the US Food and Drug Administration (FDA) has approved Columvi (glofitamab...